Organogenesis Holdings (ORGO) Income from Non-Controlling Interests (2017)
Organogenesis Holdings (ORGO) posted quarterly Income from Non-Controlling Interests of $273000.0 for Q2 2017, down 53.73% quarter-over-quarter from $590000.0 in Q1 2017.
Organogenesis Holdings (ORGO) Income from Non-Controlling Interests (2017) Analysis & Trends
Organogenesis Holdings' Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at $273000.0 for Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 376,434.15 |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Organogenesis Holdings | 242.55 Mn | 195.71 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 273,000.00 |
| Mar 31, 2017 | 590,000.00 |